|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
38th ERA-EDTA Congress | ||||||||||||||||
March 01, 2001 | ||||||||||||||||
ERA-EDTA, Vienna, Austria 24-27 June 2001 Monday 25/06/2001 GUEST LECTURE 1 Angiogenesis HALL A 8.30 - 9.00 ERA-EDTA Registry HALL D 8.30 - 9.00 Symposium 1 Acute renal failure in the new millennium Pathophysiology of ARF in the intensive care unit Extracorporeal treatment modalities and dosage in ARF patients: continuous versus discontinuous The role of the nephrologist in the management of ARF HALL A 9.00 - 10.30 Symposium 2 New Biocompatible PD solutions: the future is now Local effects of new PD solutions: cellular and molecular aspects Systemic effects of new PD solutions Clinical experience with combined use of the new solutions HALL B 9.00 - 10.30 Controversy 1 New Vitamine D analogues - Do they offer therapeutic advantages? Hot Topics HALL C 9.00 - 10.30 Symposium 3 Treatment of systemic vasculitis Current therapy and complications in systemic vasculitis The results of the CYCAZERAM and NORAM studies New drug regimens in the treatment of systemic vasculitis HALL D 9.00 - 10.30 Symposium 4 Allograft rejection: new insights Humoral rejection Subclinical rejection Chronic rejection HALL E 9.00 - 10.30 Symposium 5 Treatment resistance in progressive renal function loss Interindividual variability and treatment resistance- dose response and treatment resistance Gene and environment interaction in relation to treatment resistance Combination therapy for treatment resistance in renal disease Dietary measures to overcome treatment resistance HALL F 9.00 - 10.30 Symposium 6 Transport mechanisms of the proximal tubule Molecular pathophysiology of renal transport Endocytosis of the proximal tubules Proximal tubulus divalent anion transport HALL G 9.00 - 10.30 Symposium 7 Hyperhomocysteinaemia in renal disease Disturbance of homocysteine metabolism in renal disease Laboratory analyses and molecular genetics of homocysteine Clinical aspects of hyperhomocysteinemia in renal disease HALL H 9.00 - 10.30 GUEST LECTURE 2 Challenges to achieve clinical transplantation tolerance HALL A 14.00 - 14.30 Symposium 8 The genetics of hypertension and renal diseases Molecular genetics of hypertension New genes controlling phosphaturia Molecular genetics of diabetic nephropathy HALL A 16.30 - 18.00 Symposium 9 Secondary hyperparathyroidism and renal bone disease New aspects of parathyroid physiology and pathophysiology Which biochemical parameters are useful for the diagnosis of renal bone disease? Clinical experience with calcimimetics HALL B 16.30 - 18.00 Symposium 10 New insights into progression: role of renin-angiotensin-aldosterone system (RAAS) Role of RAAS in interstitial damage Aldosterone in progressive renal disease ACE polymorphism - an introduction of pharmacogenetics in nephrology HALL C 16.30 - 18.00 Symposium 11 Ischemic heart disease in chronic renal failure Diagnostic problems in the uraemic patient with coronary heart disease Clinical outcome following coronary stenting or balloon angioplasty in dialysis patients Ischemic heart disease risk after renal transplantation HALL D 16.30 - 18.00 Symposium 12 Transplantation: new developments New immunosuppressive drugs Gene polymorphisms and renal transplantation Immune tolerance and gene therapy in transplantation HALL E 16.30 - 18.00 Symposium 13 New advances in Continuous Flow Peritoneal Dialysis (CFPD) Background and need for CFPD: a critical reappraisal Improved small solute removal: predictions vs experimental results Preliminary experience with CFPD HALL F 16.30 - 18.00 Symposium 14 Renal replacement therapies of the future Bioartificial kidney Metanephroi transplantation Tissue Engineered Kidney HALL G 16.30 - 18.00 Symposium 15 New pathogenetic and therapeutic aspects of diabetic nephropathy Cellular molecular defects in diabetic nephropathy The polyol pathway in diabetic nephropathy Novel therapeutic targets in diabetic nephropathy HALL H 16.30 - 18.00 Tuesday 26/06/2001 GUEST LECTURE 3 TONY RAINE MEMORIAL LECTURE ON CARDIOVASCULAR DISEASE Nephroangiosclerosis: a journey through blood pressure, atherosclerosis, aging and genes HALL A 8.30 - 9.00 ERA-EDTA Registry 2 HALL D 8.30 - 9.00 Symposium 16 On-line monitoring: targets and devices Dialysis dose and sodium balance Blood volume monitoring Urea sensors and beyond HALL A 9.00 - 10.30 Symposium 17 Treatment of diabetic nephropathy in the new millennium AGEs counteraction Glycosaminoglycans Comparison of different antihypertensive strategies: study in type II diabetics HALL B 9.00 - 10.30 Symposium 18 Microalbuminuria: a predictor of cardiovascular and renal risk Predictive value in the general population and in essential hypertension Predictive value in type II diabetes Endothelial dysfunction and the kidney HALL C 9.00 - 10.30 Symposium 19 Hypertension and the kidney Evaluation of renal function in large hypertension trials: a systematic review Target blood pressure in high risk patient population Renal disease progression and ACE inhibition: a meta-analysis across the Atlantic HALL D 9.00 - 10.30 Symposium 20 Transplantation: expanding the donor pool? The marginal donor The non-heart-beating kidney donor Old kidneys for aging recipients? Ethical selection of living kidney donors HALL E 9.00 - 10.30 Controversy 2 Haematocrit normalisation in dialysis patients: yes or no Anemia management in the U.S. - A call to action HALL F 9.00 - 10.30 Symposium 21 New insights in extracellular matrix Renal pathology and extracellular matrix Matrix metabolism: the role of metalloproteinases Control of extracellular matrix assembly HALL G 9.00 - 10.30 EKRA HALL H 9.00 - 10.30 EKRA HALL H 11.00 - 12.30 GUEST LECTURE 4 Sexual hormonal replacement therapy in chronic renal failure HALL A 14.00 - 14.30 EKRA HALL H 14.30 - 16.00 Wednesday 27/06/2001 GUEST LECTURE 5 Aquaporins in physiology and pathology HALL A 8.30 - 9.00 Symposium 22 Cardiovascular risk factors in renal disease Serum creatinine as a cardiovascular risk factor Role of hyperphosphatemia and hypercalcemia in the development of vascular calcifications Hyperphosphatemia as a mortality risk factor for dialysis patients HALL A 11.00 - 12.30 Symposium 23 Different approaches in vascular access management Surgical procedures to maintain vascular access patency Interventional radiology for vascular access patency Pharmacological approach to vascular access thrombosis Gene therapy for vein grafts HALL C 11.00 - 12.30 Controversy 3 Atherosclerotic renal artery stenosis: angioplasty versus drug treatment HALL D 11.00 - 12.30 Symposium 24 Indication for combined transplants Kidney - Heart Kidney - Liver Kidney - Pancreas HALL E 11.00 - 12.30 Symposium 25 Clinical epidemiology in nephrology: the basics Experimental and observational studies and research strategies Meta-analysis Survival analysis: a primer HALL F 11.00 - 12.30 Symposium 26 Best Practice Guidelines - HD and PD HALL G 11.00 - 12.30 |
||||||||||||||||
Organized by: | ERA-EDTA Congress Office | |||||||||||||||
Invited Speakers: | not available for the moment | |||||||||||||||
Deadline for Abstracts: | 31/01/2001 | |||||||||||||||
Registration: | EARLY PRE-REGISTRATION 28/02/2001 LATE PRE- REGISTRATION 15/05/2001 AFTER 15/05/2001 ONLY ON-SITE REGISTRATIONS WILL BE POSSIBLE |
|||||||||||||||
E-mail: | congress@euromeetings.it | |||||||||||||||
Posted by: | Francesca Trebelli | |||||||||||||||
Host: | adsl-164-223.38-151.net24.it | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |